Search

Search Constraints

You searched for: Author/Creator Olsen, Inge C

Search Results

1. Active conventional treatment and three different biological treatments in early rheumatoid arthritis: phase IV investigator initiated, randomised, observer blinded clinical trial. (2nd December 2020)

3. CRP and ASDAS are associated with future elevated arterial stiffness, a risk marker of cardiovascular disease, in patients with ankylosing spondylitis: results after 5-year follow-up. Issue 8 (20th March 2015)

5. Feasibility of cardiovascular disease risk assessments in rheumatology outpatient clinics: experiences from the nationwide NOCAR project. Issue 2 (1st October 2018)

6. Genetic risk scores and number of autoantibodies in patients with rheumatoid arthritis. Issue 4 (13th December 2013)

7. Predicting achievement of the treatment targets at 6 months from 3-month response levels in rheumatoid arthritis: data from real-life follow-up in the NOR-DMARD study. Issue 2 (26th October 2018)

8. Switching from originator infliximab to biosimilar CT-P13 compared with maintained treatment with originator infliximab (NOR-SWITCH): a 52-week, randomised, double-blind, non-inferiority trial. Issue 10086 (10th June 2017)

9. Tumour necrosis factor inhibitor treatment and occurrence of anterior uveitis in ankylosing spondylitis: results from the Swedish biologics register. Issue 9 (2nd March 2017)